Kuros Biosciences Stock
Kuros Biosciences AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Switzerland
- CEO
- Christopher T. Fair
- Employees
- 213
- Market cap
- CHF667 M
- IPO
- 29/10/2002
- Web
- kurosbio.com
Kuros Biosciences AG is a healthcare company dedicated to the development and market introduction of advanced therapeutic solutions for tissue regeneration and bone repair. Headquartered in Schlieren, Switzerland, the company is listed on the SIX Swiss Exchange. Its business activities are structured into three main…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Kuros Biosciences stock: price history
1D
-9.1%
1W
-8.4%
1M
-0.9%
6M
-32.6%
YTD
-38.9%
1Y
-48.5%
2Y
-27.9%
5Y
+646.7%
10Y
-5.6%
Next earnings date
Next earnings date
03/03/2027 (in 137 days)
Volatility around earnings
~45% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Kuros Biosciences
Kuros Biosciences stock metrics
P/E
92.82
P/B
9.21
EV/EBITDA
57.96
RETURN ON EQUITY
4.8%
NET MARGIN
4.8%
DEBT/EQUITY
0.15
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
72.1%
FLOAT SHARES
28,607,848
AVG. DAILY VOLUME (30D)
214,819
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Kuros Biosciences stock
What does Kuros Biosciences do?
Kuros Biosciences AG is a company in the Healthcare sector, Medical - Devices industry, headquartered in Switzerland.
The CEO is Christopher T. Fair, the company employs around 213 people.
The IPO was on 29/10/2002; the stock trades on SIX under the ticker KURN.SW.
When does Kuros Biosciences report next?
The next earnings date is 03/03/2027.
Around past earnings, price swings were roughly -45% stronger than usual.
Does Kuros Biosciences pay a dividend?
No, Kuros Biosciences currently does not pay a dividend.
Which stocks are comparable to Kuros Biosciences?
Comparable stocks include Sonova Holding, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers and DexCom.
How can I get Kuros Biosciences stock analyzed?
Clicking "Analyze stock" lets five strategies assess Kuros Biosciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.